Back

Disparities in Naltrexone Prescriptions to Medicaid Enrollees During the COVID-19 Pandemic

2022-10-07 addiction medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundThe COVID-19 pandemic strained healthcare facilities and the isolation and uncertainty associated with the pandemic compromised mental health around the world. The pandemic has also been associated with an exacerbation of the opioid crisis in the United States (US), and previous studies have reported changing trends in opioid misuse during the pandemic. Our study investigated naltrexone, a prescription drug used to treat alcohol and opioid use disorders by blocking opioid receptors to ...

Predicted journal destinations

1
Drug and Alcohol Dependence
21 training papers
#1 25.4%
2
Addiction
24 training papers
Top 0.2% 12.5%
3
JAMA Network Open
125 training papers
#1 12.5%
4
PLOS ONE
1737 training papers
Top 58% 10.3%
5
Neuropsychopharmacology
29 training papers
Top 0.2% 6.8%
6
Frontiers in Psychiatry
56 training papers
Top 1.0% 6.8%
7
Translational Psychiatry
94 training papers
Top 5% 3.5%
8
Brain Stimulation
27 training papers
Top 2% 1.7%
9
Scientific Reports
701 training papers
Top 86% 1.5%
10
International Journal of Environmental Research and Public Health
116 training papers
Top 21% 1.3%
11
JMIR Public Health and Surveillance
45 training papers
Top 4% 1.1%
12
BMJ Open
553 training papers
Top 61% 1.1%
13
Biological Psychiatry
36 training papers
Top 5% 0.8%
14
PLOS Digital Health
88 training papers
Top 18% 0.8%
15
Molecular Psychiatry
84 training papers
Top 9% 0.8%
16
BMC Health Services Research
43 training papers
Top 5% 0.8%
17
PLOS Medicine
95 training papers
Top 29% 0.5%
18
PLOS Global Public Health
287 training papers
Top 37% 0.5%
19
BMC Public Health
148 training papers
Top 32% 0.5%
20
Journal of Medical Internet Research
81 training papers
Top 25% 0.5%
21
Journal of General Internal Medicine
19 training papers
Top 2% 0.5%
22
The British Journal of Psychiatry
21 training papers
Top 5% 0.5%